Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Variant Study in the Introns 1 and 2 of PAX5 Gene in the Patients With Acute Lymphoblastic Leukemia Disease

Shokoufeh Yazdanparast 1 , Saeid Reza Khatami 1 , * , Hamid Galehdari 1 , Ahmad Ahmadzadeh 2 and Kaveh Jaseb 2
Authors Information
1 Department of Genetic, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
2 Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: May 31, 2016, 18 (5); e6670
  • Published Online: May 16, 2016
  • Article Type: Research Article
  • Received: December 9, 2014
  • Accepted: January 31, 2015
  • DOI: 10.17795/zjrms-6670

To Cite: Yazdanparast S, Khatami S R, Galehdari H, Ahmadzadeh A, Jaseb K. Variant Study in the Introns 1 and 2 of PAX5 Gene in the Patients With Acute Lymphoblastic Leukemia Disease, Zahedan J Res Med Sci. 2016 ; 18(5):e6670. doi: 10.17795/zjrms-6670.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mullighan CG, Willman CL. Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic. J Adolesc Young Adult Oncol. 2011; 1(2): 77-86[DOI][PubMed]
  • 2. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005; 14(1): 53-62[DOI][PubMed]
  • 3. Downing JR, Mullighan CG. Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006; : 118-22[DOI][PubMed]
  • 4. Figueroa ME, Chen SC, Andersson AK, Phillips LA, Li Y, Sotzen J, et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest. 2013; 123(7): 3099-111[DOI][PubMed]
  • 5. Rahimi Z, Rahimi Z, Akramipour R. Prothrombin G20210A Mutation is not a Risk Factor for Pediatric Acute Lymphoblastic Leukemia in Western Iran. Middle East Journal of Cancer. 2013; 4(4): 139-43
  • 6. Teitell MA, Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol. 2009; 4: 175-98[DOI][PubMed]
  • 7. Meijerink JP, den Boer ML, Pieters R. New genetic abnormalities and treatment response in acute lymphoblastic leukemia. Semin Hematol. 2009; 46(1): 16-23[DOI][PubMed]
  • 8. Medvedovic J, Ebert A, Tagoh H, Busslinger M. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol. 2011; 111: 179-206[DOI][PubMed]
  • 9. He T, Hong SY, Huang L, Xue W, Yu Z, Kwon H, et al. Histone acetyltransferase p300 acetylates Pax5 and strongly enhances Pax5-mediated transcriptional activity. J Biol Chem. 2011; 286(16): 14137-45[DOI][PubMed]
  • 10. Arseneau JR, Laflamme M, Lewis SM, Maicas E, Ouellette RJ. Multiple isoforms of <italic>PAX5</italic> are expressed in both lymphomas and normal B-cells. Br J Haematol. 2009; 147(3): 328-38[DOI][PubMed]
  • 11. Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, Storlazzi CT, et al. The <italic>PAX5</italic> gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party. Haematologica. 2010; 95(10): 1683-90[DOI][PubMed]
  • 12. McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, et al. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 2011; 30(12): 2388-404[DOI][PubMed]
  • 13. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137): 758-64[DOI][PubMed]
  • 14. Familiades J, Bousquet M, Lafage-Pochitaloff M, Bene MC, Beldjord K, De Vos J, et al. <italic>PAX5</italic> mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and <italic>PAX5</italic> haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia. 2009; 23(11): 1989-98[DOI][PubMed]
  • 15. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003; 17(4): 419-37[DOI][PubMed]
  • 16. Najjar Sadeghi R, Damavand B, Vahedi M, Mohebbi SR, Zojazi H, Molaei M, et al. Detection of p53 common intron polymorphisms in patients with gastritis lesions from Iran. Asian Pac J Cancer Prev. 2013; 14(1): 91-6[PubMed]
  • 17. Majewski J, Ott J. Distribution and characterization of regulatory elements in the human genome. Genome Res. 2002; 12(12): 1827-36[DOI][PubMed]
  • 18. Fitzsimmons D, Lukin K, Lutz R, Garvie CW, Wolberger C, Hagman J. Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5. J Mol Biol. 2009; 392(2): 452-64[DOI][PubMed]
  • 19. Blake JA, Ziman MR. Pax genes: regulators of lineage specification and progenitor cell maintenance. Development. 2014; 141(4): 737-51[DOI][PubMed]
  • 20. O'Brien P, Morin PJ, Ouellette RJ, Robichaud GA. The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res. 2011; 71(24): 7345-50[DOI][PubMed]
  • 21. An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV, et al. Variable breakpoints target <italic>PAX5</italic> in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci U S A. 2008; 105(44): 17050-4[DOI][PubMed]
  • 22. Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, et al. Wide diversity of <italic>PAX5</italic> alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood. 2010; 115(15): 3089-97[DOI][PubMed]
  • 23. Zwollo P, Arrieta H, Ede K, Molinder K, Desiderio S, Pollock R. The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem. 1997; 272(15): 10160-8[PubMed]
  • 24. Arenas M, Duley J, Sumi S, Sanderson J, Marinaki A. The ITPA c.94C&gt;A and g.IVS2+21A&gt;C sequence variants contribute to missplicing of the ITPA gene. Biochim Biophys Acta. 2007; 1772(1): 96-102[DOI][PubMed]
  • 25. Harland M, Mistry S, Bishop DT, Bishop JA. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet. 2001; 10(23): 2679-86[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments